The pharmaceutical industry’s most elegant competitive weapon is also its most misunderstood. When a brand-name drug manufacturer launches its own […]

The Date That Actually Controls Generic Entry Walk into almost any pharmaceutical business development meeting, and the discussion of competitive

The moment a pharmaceutical brand company files a new drug application with the FDA, a clock starts ticking. Somewhere across

How pharmaceutical companies engineer consumer psychology to extract billions from brand loyalty after patents expire — and what it means

Pharmaceutical brand teams spend millions monitoring what doctors, patients, and payers say about their drugs. Most of that investment goes

Every pharmaceutical company files patents to protect its investment. Every one of those patents is a public document. And yet,

The Fork in the Road That Determines Billions When a drug company files for FDA approval of a new medicine,

A complete operational guide to locating abandoned and lapsed pharmaceutical patents for generic market entry The Money Is in the

The Moment Everyone Prepares for and Nobody Fully Survives The day a blockbuster drug’s core patent expires is circled on